EuroEyes International Eye Clinic Limited (HKG:1846)
Hong Kong · Delayed Price · Currency is HKD 2.380
+0.010 (0.42%)
Sep 2, 2026, 1:49 PM HKT
HKG:1846 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 873.25 | 796.04 | 715.68 | 714.29 | 610.29 | 632.93 | |
Revenue Growth | 20.54% | 11.23% | 0.19% | 17.04% | -3.58% | 33.58% |
Cost of Revenue | 526.75 | 471.71 | 429.09 | 378.77 | 339.45 | 320.39 |
Gross Profit | 346.5 | 324.33 | 286.59 | 335.52 | 270.84 | 312.55 |
Selling, General & Admin | 292.14 | 209.32 | 185.48 | 162.22 | 134.01 | 122.75 |
Other Operating Expenses | 5.83 | -1.66 | -3.94 | -4.86 | -3.95 | -1.87 |
Operating Expenses | 298.13 | 207.82 | 181.88 | 157.58 | 130.1 | 120.99 |
Operating Income | 48.36 | 116.51 | 104.72 | 177.94 | 140.75 | 191.56 |
Interest Expense | - | -9.27 | -10.04 | -9.7 | -7.12 | -7.49 |
Interest & Investment Income | 20.13 | 13.36 | 23.57 | 19.33 | 1.14 | 0.14 |
Currency Exchange Gain (Loss) | -14.06 | -14.06 | 2.9 | -8.09 | 5.77 | 12.74 |
Other Non Operating Income (Expenses) | 0.75 | -2.21 | -5.75 | -4.44 | -3.62 | -0.97 |
EBT Excluding Unusual Items | 55.18 | 104.32 | 115.4 | 175.04 | 136.92 | 195.97 |
Merger & Restructuring Charges | - | - | - | - | -3.29 | - |
Impairment of Goodwill | - | - | -11 | - | - | - |
Gain (Loss) on Sale of Assets | 2.67 | 2.67 | -1.08 | -0.38 | 0.21 | -0.29 |
Other Unusual Items | -4.55 | -4.55 | 23.15 | 15.96 | -4.85 | - |
Pretax Income | 53.3 | 102.44 | 126.47 | 190.61 | 128.98 | 195.67 |
Income Tax Expense | 48.84 | 45.81 | 42.11 | 57.36 | 45.46 | 63.29 |
Earnings From Continuing Operations | 4.46 | 56.63 | 84.36 | 133.25 | 83.52 | 132.38 |
Minority Interest in Earnings | -1.97 | -2.18 | -2.07 | -2.01 | 5.95 | 1.18 |
Net Income | 2.49 | 54.45 | 82.29 | 131.24 | 89.47 | 133.56 |
Net Income to Common | 2.49 | 54.45 | 82.29 | 131.24 | 89.47 | 133.56 |
Net Income Growth | -96.75% | -33.83% | -37.30% | 46.69% | -33.01% | 103.66% |
Shares Outstanding (Basic) | 319 | 320 | 330 | 332 | 332 | 328 |
Shares Outstanding (Diluted) | 319 | 320 | 330 | 332 | 332 | 329 |
Shares Change | -1.60% | -3.17% | -0.60% | -0.01% | 0.95% | -12.38% |
EPS (Basic) | 0.01 | 0.17 | 0.25 | 0.40 | 0.27 | 0.41 |
EPS (Diluted) | 0.01 | 0.17 | 0.25 | 0.40 | 0.27 | 0.41 |
EPS Growth | -96.70% | -31.66% | -36.93% | 46.70% | -33.64% | 132.43% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 138.71 | 148.11 | 117.41 | 102.94 | 152.74 | 229.28 |
Free Cash Flow Per Share | 0.43 | 0.46 | 0.36 | 0.31 | 0.46 | 0.70 |
Dividend Per Share | 0.044 | 0.044 | 0.065 | 0.100 | 0.063 | 0.099 |
Dividend Growth | 48.48% | -31.73% | -35.40% | 59.59% | -36.91% | 232.40% |
Gross Margin | 39.68% | 40.74% | 40.04% | 46.97% | 44.38% | 49.38% |
Operating Margin | 5.54% | 14.64% | 14.63% | 24.91% | 23.06% | 30.26% |
Profit Margin | 0.29% | 6.84% | 11.50% | 18.37% | 14.66% | 21.10% |
Free Cash Flow Margin | 15.88% | 18.61% | 16.41% | 14.41% | 25.03% | 36.23% |
EBITDA | 106.27 | 172.67 | 151.85 | 215.12 | 174.54 | 220.08 |
EBITDA Margin | 12.17% | 21.69% | 21.22% | 30.12% | 28.60% | 34.77% |
D&A For EBITDA | 57.9 | 56.16 | 47.13 | 37.18 | 33.79 | 28.52 |
EBIT | 48.36 | 116.51 | 104.72 | 177.94 | 140.75 | 191.56 |
EBIT Margin | 5.54% | 14.64% | 14.63% | 24.91% | 23.06% | 30.26% |
Effective Tax Rate | 91.63% | 44.71% | 33.30% | 30.09% | 35.25% | 32.34% |